This program represents a multidiciplinary approach towards developing new diagnostic and prognostic indicators for breast cancer. This approach tests the hypothesis that recent advances in molecular and cellular biology using model systems are ready to be applied directly to the problem of human breast cancer. The research projects will concentrate on three areas; 1) oncogene expression, by comparing normal and malignant breast epithelial cells in short-term culture for expression of known oncogenes and for activation or amplification of potentially new oncogenes; 2) genetic instability, by examining cultured breast cells for loss of heterozygosity using restriction fragment length polymorphism analysis and for their capacity to generate gene amplifications, and 3) stromal-epithelial interactions looking for systemic manifestations of breast cancer by comparing skin and breast- derived fibroblasts from normal donors and breast cancer patients for expression of extracellular matrix components, cell phenotype differences, and stromal interactions with breast epithelial cells. The Program's Clinical Core will provide the projects and the other cores with surgical breast specimens and fine needle aspiration material, will conduct the clinical protocols designed to obtain new prognostic data about tumor cell kinetics, and in association with the Administrative Core will provide clinical data and prospective follow-up information on all patients whose tumor samples are being analyzed. The Cell Biology Core will process and bank benign and malignant breast tissue specimens, producing homogeneous preparations of epithelial and stromal cells which can be propagated and expanded in short-term cultures for use by the research projects. This core, in association with the Cytometry and Biostatics Core, will also routinely characterize all biopsy and fine-needle aspiration material using a panel of monoclonal antibodies and analytical procedures to quantify cellular phenotypic markers and indices of tumor cytokinetics. These molecular and cellular studies will be used to optimize and augment the routine assays being performed on biopsy material. Hopefully, the results from these studies will impact on breast cancer survival by improving our diagnostic and prognostic indicators, as well as by providing new scientific insights into breast cancer pathophysiology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
7P01CA044768-03
Application #
3094158
Study Section
Cancer Therapeutics Program Project Review Committee (CTR)
Project Start
1987-06-01
Project End
1990-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Medical Research Institute of San Fran
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94115
Hwang, E Shelley; DeVries, Sandy; Chew, Karen L et al. (2004) Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 10:5160-7
Shelley Hwang, E; Nyante, Sarah J; Yi Chen, Yunn et al. (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100:2562-72
Gupta, Anu; Yang, Li Xi; Chen, Ling chun (2002) Study of the G2/M cell cycle checkpoint in irradiated mammary epithelial cells overexpressing Cul-4A gene. Int J Radiat Oncol Biol Phys 52:822-30
Neve, Richard M; Ylstra, Bauke; Chang, Chuan-Hsiung et al. (2002) ErbB2 activation of ESX gene expression. Oncogene 21:3934-8
Thor, Ann D; Eng, Clarence; Devries, Sandy et al. (2002) Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum Pathol 33:628-31
Gong, G; DeVries, S; Chew, K L et al. (2001) Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 7:2410-4
Etzell, J E; Devries, S; Chew, K et al. (2001) Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32:292-6
Liu, S; Edgerton, S M; Moore 2nd, D H et al. (2001) Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res 7:1716-23
Waldman, F M; Hwang, E S; Etzell, J et al. (2001) Genomic alterations in tubular breast carcinomas. Hum Pathol 32:222-6
Neve, R M; Nielsen, U B; Kirpotin, D B et al. (2001) Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function. Biochem Biophys Res Commun 280:274-9

Showing the most recent 10 out of 133 publications